Clinical Trials Browser

Phase 1/2 × Withdrawn × Leukemia, B-Cell × Clear all

NCT03098355 2024-03-18

Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT05570188 2022-11-30

Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell